OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
5.16
+0.25 (5.09%)
Mar 19, 2025, 12:32 PM EDT - Market open
OnKure Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 10.37 | 4.82 | 3.9 |
| Research & Development | 43.17 | 32.12 | 25.86 |
| Operating Expenses | 53.54 | 36.93 | 29.77 |
| Operating Income | -53.54 | -36.93 | -29.77 |
| Interest Expense | -0.15 | - | - |
| Interest & Investment Income | 2.01 | 1.62 | 0.25 |
| Other Non Operating Income (Expenses) | -0.04 | - | - |
| EBT Excluding Unusual Items | -51.71 | -35.31 | -29.51 |
| Merger & Restructuring Charges | -0.23 | - | - |
| Other Unusual Items | -0.74 | - | - |
| Pretax Income | -52.67 | -35.31 | -29.51 |
| Net Income | -52.67 | -35.31 | -29.51 |
| Net Income to Common | -52.67 | -35.31 | -29.51 |
| Shares Outstanding (Basic) | 3 | 0 | - |
| Shares Outstanding (Diluted) | 3 | 0 | - |
| Shares Change (YoY) | 1114.54% | - | - |
| EPS (Basic) | -15.28 | -124.41 | - |
| EPS (Diluted) | -15.28 | -124.41 | - |
| Free Cash Flow | -51.17 | -34.79 | -28.09 |
| Free Cash Flow Per Share | -14.84 | -122.59 | - |
| EBITDA | -53.08 | -36.52 | -29.54 |
| D&A For EBITDA | 0.46 | 0.42 | 0.23 |
| EBIT | -53.54 | -36.93 | -29.77 |
Source: S&P Capital IQ. Standard template.
Financial Sources.